| Product NDC: | 16590-871 | 
| Proprietary Name: | ZANAFLEX | 
| Non Proprietary Name: | TIZANIDINE HYDROCHLORIDE | 
| Active Ingredient(s): | 4 mg/1 & nbsp; TIZANIDINE HYDROCHLORIDE | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | CAPSULE | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 16590-871 | 
| Labeler Name: | STAT RX USA LLC | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA021447 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 20020829 | 
| Package NDC: | 16590-871-60 | 
| Package Description: | 60 CAPSULE in 1 BOTTLE (16590-871-60) | 
| NDC Code | 16590-871-60 | 
| Proprietary Name | ZANAFLEX | 
| Package Description | 60 CAPSULE in 1 BOTTLE (16590-871-60) | 
| Product NDC | 16590-871 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | TIZANIDINE HYDROCHLORIDE | 
| Dosage Form Name | CAPSULE | 
| Route Name | ORAL | 
| Start Marketing Date | 20020829 | 
| Marketing Category Name | NDA | 
| Labeler Name | STAT RX USA LLC | 
| Substance Name | TIZANIDINE HYDROCHLORIDE | 
| Strength Number | 4 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |